Mitotane (Lysodren®) in Der Therapie Des Nebennierenrindenkarzinoms
Austrian Journal of Clinical Endocrinology and Metabolism - Austria
doi 10.1007/s41969-019-0070-y
Full Text
Open PDFAbstract
Available in full text
Date
August 12, 2019
Authors
Publisher
Springer Science and Business Media LLC